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Abstract
Background: Alveolar echinococcosis (AE) is a severe chronic hepatic parasitic disease currently emerging in central and
eastern Europe. Untreated AE presents a high mortality (.90%) due to a severe hepatic destruction as a result of parasitic
metacestode proliferation which behaves like a malignant tumor. Despite this severe course and outcome of disease, the
genetic program that regulates the host response leading to organ damage as a consequence of hepatic alveolar
echinococcosis is largely unknown.
Methodology/Principal Findings: We used a mouse model of AE to assess gene expression profiles in the liver after
establishment of a chronic disease status as a result of a primary peroral infection with eggs of the fox tapeworm
Echinococcus multilocularis. Among 38 genes differentially regulated (false discovery rate adjusted p#0.05), 35 genes were
assigned to the functional gene ontology group ,immune response., while 3 associated with the functional group
,intermediary metabolism.. Upregulated genes associated with ,immune response. could be clustered into functional
subgroups including ,macrophages., ,APCs., ,lymphocytes, chemokines and regulation., ,B-cells. and
,eosinophils.. Two downregulated genes related to ,lymphocytes, chemokines and regulation. and ,intermediary
metabolism., respectively. The ,immune response. genes either associated with an ,immunosupression. or an
,immunostimulation. pathway. From the overexpressed genes, 18 genes were subsequently processed with a Custom
Array microfluidic card system in order to assess respective expression status at the mRNA level relative to 5 reference genes
(Gapdh, Est1, Rlp3, Mdh-1, Rpl37) selected upon a constitutive and stable expression level. The results generated by the two
independent tools used for the assessment of gene expression, i.e., microarray and microfluidic card system, exhibited a
high level of congruency (Spearman correlation rho = 0.81, p = 7.87e-5) and thus validated the applied methods.
Conclusions/Significance: Based on this set of biomarkers, new diagnostic targets have been made available to predict
disease status and progression. These biomarkers may also offer new targets for immuno-therapeutic intervention.
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Introduction
Alveolar echinococcosis (AE) is a result of a hepatic infection
with the larval (metacestode) stage of the fox tapeworm Echinococcus
multilocularis. AE as a disease is associated with high mortality
(.90%) if remaining untreated [1]. AE patients are affected by
hepatic sequelae that are due to a wide spectrum of liver injury
leading predominantly to cholestatic jaundice (about a third of
cases) and/or unspecific epigastric pain (about a third of cases),
together with various symptoms such as fatigue, weight loss and
hepatomegaly [2].
As a result of peroral infection via eggs of E. multilocularis, the
parasitic metacestode (larval stage) subsequently grows as a tumor-
like tissue in the liver of its intermediate host, include
predominantly small rodents, but accidentally also humans. Thus,
the laboratory mouse is an excellent model to study the host-
parasite interplay. While most studies so far have been carried
out upon so-called secondary infections (intraperitoneal inocula-
tion of fully developed metacestode tissue), the respective difficulty
lies in the fact that this infection model does not include primary
hepatic events that are crucial to understand the natural host-
parasite interplay. The real approach to determining the biological
events in vivo is to carry out peroral inoculation of infectious E.
multilocularis eggs, experiments that can only be performed in
appropriate biosafety level 3 laboratory units. Such experimental
infection is referred to as primary infection, resulting in an
intrahepatic tumor-like growth of the metacestode that over-
comes the immune system and subsequently establishes a chronic
phase of infection, which persists approximately between 4–6
months p.i.. Through effects on cells of both the innate and
adaptive arms of the immune response, the parasite can
orchestrate a range of outcomes that are beneficial not only for
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metacestode establishment, but also in terms of facilitating its
proliferation and maturation. In addition, the complex host-
parasite interaction leads to only limited pathology. Likewise, a
higher survival potential for both host and parasite is achieved.
Despite the severity of AE in humans, the genetic program that
regulates the mechanisms leading to liver damage as a conse-
quence of AE is largely unknown. High-throughput methods, e.g.
DNA microarrays, can provide a comprehensive picture of the
genes underlying the host responses to AE. This knowledge is a
prerequisite for understanding the pathogenesis of liver damage
and can drive the development of new prognostic and/or
therapeutic modalities for AE. The aim of this study was to
identify genes and sets of genes implicated in the immuno-
pathophysiological mechanisms leading to the induction of a host
response to infection, but subsequently also to hepatic damage
observed in experimental AE. We used an appropriate mouse
model of primary AE infection and DNA microarray technology
to assess gene expression profiles in the periparasitic liver tissue
known to be preferentially affected, in mock-infected controls and
during the phase of early chronic AE following peroral infection of
the mice with infectious E. multilocularis eggs (thus exactly
mimicking the natural way of infection). Significantly overex-
pressed genes on microarrays were re-investigated and validated
by real-time RT-PCR using microfluidic cards.
Results
Animal model
Eight to 10-week-old female BALB/c mice were purchased
from Charles River GmbH, Germany. For all experiments,
animals were matched for age and weight. All mice were housed
and handled under standard aseptic animal laboratory conditions
according to the rules of the Swiss regulations for animal
experimentation. Maintenance of perorally E. multilocularis egg
infected animals (see below) was carried out in a B3 safety
containment, these experiments required governmental safety
approval (Swiss Federal concession no. A990006/3A). Primary
infections of mice were all based upon the use of a single batch of
E. multilocularis eggs, obtained and purified as previously described
[3]. The viability and infectivity rate of this batch of eggs had been
predetermined by appropriate explorative titration-infection trials
in mice [4]. For the present batch and experiments, primary
infection parameters were 2,000 eggs per mouse to be adminis-
tered perorally, yielding a medium number of 26 primary lesions
per liver (range 12–35). Technically, intragastric E. multilocularis
egg inoculation was performed as described elsewhere [5]. 31 days
after infection, all infected animals (n = 8) had alveolar echino-
coccosis of the liver as evidenced by the presence of between 5 to
22 hepatic liver lesions, all exhibiting the same morphology
including a central parasitic vesicle of approximately 1–2 mm of
diameter, and surrounded by a white periparasitic inflammatory
corona of about 0.5 mm in diameter. Mock-infected control
animals presented neither macroscopically nor microscopically
visible lesions in the liver.
Microarrays
Changes of the mouse hepatic gene expression in response to
primary hepatic E. multilocularis infection were examined during
the initial phase of chronic infection stage (i.e. after 1 month). The
parasitized animals shared a total of 38 genes that significantly
changed after 1 mon of infection (fdr adjusted P-value of ,0.05)
(Tab. 1). Of those genes, 36 appeared upregulated in reference to
non-infected controls, and 2 yielded down-regulation.
Microfluidic card system mRNA assessment
From the overexpressed genes, 18 genes were subsequently
investigated with a TaqManH Custom Array microfluidic card system
in order to assess respective expression status at the mRNA level in
reference to 5 reference genes (Gapdh, Est1, Rlp3, Mdh-1, Rpl37). In
Table 2, up- and downregulation were calculated from real time data,
genes were clustered according to the mode used for Table 1.
When comparing microarray and microfluidic card system, they
exhibited a high level of congruency (Spearman correlation
rho= 0.81, p = 7.87e-5).
Overview of differential gene regulation
Most (34 from 36, 94%) of upregulated genes were annotated to
,defense and immune response. processes, while 2 genes (6%)
were annotated to ,intermediary metabolism. of hepatocytes.
Upregulated genes associated with ,immune response/defense.
(n= 34) could be clustered into functional subgroups including
,macrophages. (n= 15), ,APCs. (n= 6), ,lymphocytes, che-
mokines and regulation. (n= 10), ,B-cells. (n= 2) and ,eosin-
ophils. (n= 1). Two downregulated genes related to,lymphocytes,
chemokines and regulation. and ,intermediary metabolism.,
respectively (Tab. 1).
The ,immune response. genes (n = 35) either associated with
an ,immunosupression. or an ,immunostimulation. pathway,
are schematically drawn in (Fig. 1).
In the following paragraph, first upregulated, then downregu-
lated genes will be presented more in details:
Immune response/defense [MØ]; up-regulated
BC023105, Tgtp, Gvin1. These belong to the interferon-
inducible p47 GTPases. Interferons (with a preference IFN-c over
a/b) bind to their respective receptors. For Tgtp, the binding is
followed by phosphorylation of STAT1 and rapid translocation of
P-STAT1 dimers to the nucleus. There, the complex activates
transcription of p47 GTPases by binding to the IFN-c activation
site (GAS) in the promoter. The gene products enable the MØ
phagosome to be part of the innate defense of cells to infection, but
its role in such defense has not yet been clearly defined [6].
GBPs (GBP1, GBP2, 5830443L24Rik, GBP8). GBPs are
upregulated in macrophages in response to IFN-c. GBP-1 is a
large GTPase that is induced by inflammatory cytokines and acts
antiangiogenically through the inhibition of endothelial cell
proliferation and migration [7]. Interestingly, some GBPs are
upregulated in mice infected with intracellular pathogens such as
L. monocytogenes and T. gondii and are colocalized with T. gondii in
infected cells [8]. GBP-1 is also a marker of inflammation that may
protect against epithelial apoptosis induced by inflammatory
cytokines and subsequent loss of barrier function [9].
MARCO. MØ express several host-defense receptors that can
be divided into two classes; those dependent on opsonizing
components for recognizing pathogens, and those that can
recognize pathogens directly. MARCO belongs to a family of
class A scavenger with pattern recognition receptors, some of
which have been shown to bind lipopolysaccharide that are surface
components of many infectious organisms [10]. It will be of
upmost interest to search for E. multilocularis glycans such as
Em492 for their interaction potential with MØ via MARCO.
STAT1. STAT1 plays an important role in HA-mediated
inflammatory processes [11]. It has been demonstrated that IL-27
controls the development of Th17 and iTreg cells via differential
effects on STAT1 [12]. One of the main role of STAT1 is in
activating GBP2 transcription to provide transcriptionally
competent chromatin [13]. Activation of STAT1 attenuates liver
fibrosis through inhibition of HSC proliferation, attenuation of
Hepatic Gene Expression in AE
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Table 1. Probe-sets representing 38 genes, their expression levels in the liver, organized according to their functional groups.
# AFFY ID REFSEQ ID GENE
NCBI
Gene ID DESCR ratio
expr_AE-
LIVER
expr_LIVER
mock-infected
OVEREXPESSED/UPREGULATED
Immune response/defense [functional group]: Macrophages (MØ)
01 1425394_at XP_001471630 BC023105 667597 cDNA sequence aBC023105 p47-like GTPase 10 17 169
02 1449009_at NM_011579 Tgtp 21822 T-cell specific GTPase 6.6 302 2001
03 1429184_at NM_001039160 Gvin1 74558 GTPase, very large interferon inducible 1 3.3 293 954
04 1424923_at NM_009251 Serpina3g 20715 serine (or cysteine) peptidase inhibitor, member 3G 6.4 84 534
05 1420549_at NM_010259 Gbp1 14468 guanylate binding protein 1 5.0 24 118
06 1435906_x_at NM_010260 Gbp2 14469 guanylate binding protein 2 3.0 93 277
07 1418776_at NM_029509 5830443L24Rik 76074 RIKEN cDNA 5830443L24 gene, GBP-like 3.4 91 310
08 1449498_at NM_010766 Marco 17167 macrophage receptor with collagenous structure 4.7 51 236
09 1447927_at NM_194336 Mpa2l 100702 macrophage activation 2 like 3.6 342 1223
10 1440481_at NM_009283 Stat1 20846 signal transducer and activator of transcription 1 3.4 36 121
11 1436808_x_at NM_008566 Mcm5 17218 minichromosome maintenance deficient 5, 2.9 31 91
12 1420699_at NM_020008 Clec7a 56644 C-type lectin domain family 7, member a 2.8 70 193
13 1416295_a_at NM_013563 Il2rg 16186 interleukin 2 receptor, gamma chain 2.8 67 189
14 1426808_at NM_010705 Lgals3 16854 lectin, galactose binding, soluble 3, galektin 2.6 118 300
15 1448748_at NM_019549 Plek 56193 pleckstrin 2.4 29 70
Immune response/defense [functional group]: APC
16 1450648_s_at NM_207105 H2-Ab1 14961 histocompatibility 2, class II antigen A, beta 1 5.6 230 1287
17 1417025_at NM_010382 H2-Eb1 14969 histocompatibility 2, class II antigen E beta 5.3 151 796
18 1435290_x_at NM_010378 H2-Aa 14960 histocompatibility 2, class II antigen A, alpha 4.4 457 1999
19 1422527_at NM_010386 H2-Dma 14998 histocompatibility 2, class II, locus Dma 2.9 31 90
20 1418638_at NM_010387 H2-DMb1 14999 histocompatibility 2, class II, locus Mb1 2.9 15 43
21 1425519_a_at NM_001042605 Cd74 16149 CD74 antigen (invariant polypeptide of major histo
compatibility complex, class II antigen-associated)
3.8 602 2268
Immune response/defense [functional group]: Lymphocytes, chemokines and regulation
22 1418652_at NM_008599 Cxcl9 17329 chemokine (C-X-C motif) ligand 9 5.2 254 1328
23 1418126_at NM_207105 Ccl5 20304 chemokine (C-C motif) ligand 5 4.5 24 111
24 1418930_at NM_021274 Cxcl10 15945 chemokine (C-X-C motif) ligand 10 4.1 81 327
25 1423467_at NM_021718 Ms4a4b 60361 membrane-spanning 4-domains, subfamily A, CD20 3.0 25 74
26 1424638_at NM_001111099 Cdkn1a 12575 cyclin-dependent kinase inhibitor 1A (P21) 2.8 22 63
27 1452349_x_at NM_172648 Ifi205 226695 interferon activated gene 205 2.6 188 492
28 1422903_at NM_010745 Ly86 17084 lymphocyte antigen 86 2.4 211 506
29 1421855_at NM_008013 Fgl2 14190 fibrinogen-like protein 2 2.4 37 88
30 1448162_at NM_011693 Vcam1 22329 vascular cell adhesion molecule 1 2.2 118 259
31 1447830_s_at NM_009061 Rgs2 19735 regulator of G-protein signaling 2 2.3 29 67
Immune response/defense [functional group]: B-cells
32 1427455_x_at XM_001476664 Igk-V1 16081 immunoglobulin kappa chain variable 1 (V1) 4.7 90 420
33 1452417_x_a XM_001476664 Igk-C 16071 immunoglobulin kappa chain, constant region 4.4 130 574
Immune response/defense [functional group]: Eosinophils
34 1449846_at NM_007895 Ear2 13587 eosinophil-associated, ribonuclease A family, member 2 2.6 41 104
Intermediary metabolism [functional group]: hepatocytes
35 1431056_a_at NM_008509 Lpl 16956 lipoprotein lipase 2.6 358 975
36 1442798_x_at NM_001033245 Hk3 212032 hexokinase 3 2.4 37 90
DOWNREGULATED
Immune response/defense [functional group]: Lymphocytes, chemokines and regulation
37 1451069_at NM_145478 Pim3 223775 proviral integration site 3 0.4 298 118
Intermediary metabolism [functional group]: hepatocytes
38 1451588_at NM_026947 1810022C23Rik 69123 RIKEN cDNA 1810022C23 gene, Crotonase-like 0.4 278 100
In bold (AFFY ID nos.) are genes that subsequently were subjected to retesting by a microfluidic card system. Genes were selected upon = Avg Diff change factor .2.0,
and/or p.0.05 for pairwise comparisons with mock-infected liver tissue.
doi:10.1371/journal.pone.0009779.t001
Hepatic Gene Expression in AE
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TGF-beta signaling, and stimulation of NK cell killing of activated
HSCs. STAT1 could be a new therapeutic target for treating
alveolar echinococcosis, similar to that shown e.g. for liver fibrosis
[14]. Analysis of T cell responses revealed that STAT1 was not
required for the development of a Th1 response, but was required
for the infection-induced up-regulation of T-bet. Moreover, Stat1
interacts with Mcm5 and thus may trigger IFN-dependent cell
proliferation [15].
Mcm5 (CD46). Mcm5 is a member of the MCM complex
which is essential for the initiation of replication. Mcm5 is one of the
nuclear proteins that inertact with phosphorylated STAT1 and
therefore may play a role in JAK-STAT-modulated cell proliferation
[15]. Like other replication factors, Mcm5 is considered as a marker
for tumor proliferation, thus it will be interesting to study its putative
role in promoting the unrestricted metacestode proliferation
encountered in murine alveolar echinococcosis of the liver.
Il2rg (CD132), Pleckstrin, Lgals3. Naive T cells can be
induced to undergo homeostatic proliferation of variable speed
with a few members of the common gamma-chain (CD132) family
of cytokines [16]. The IL2 receptor c chain interacts with insulin
receptor substrate (IRS) proteins. These proteins have a pleckstrin
binding domain and are phosphorylated partly by JAK-kinases
[17]. Pleckstrin is involved in intracellular signaling, e.g. by PI3K
pathways that participate in IL-signalling [17], insulin signaling
and inflammatory responses [18]. Galectin-3 is a 30 kDa lectin
binding b-galactoside expressed and secreted by macrophages. It is
a chemoattractant for monocytes and macrophages. CD98 is the
receptor for galectin on the macrophage membrane and triggers
macrophage activation by the PI3K-pathway. Both components
are involved in alternative macrophage activation by IL-4 since
disruption of the galectin gene in mice restrains macrophage
activation [19].
Clec7a. The c-type lectin 7a (Dectin-1) is expressed on mono-
cytes, macrophages, and dendritic cells as a phagocytic receptor for
b-glucan containing particles. Dectin-1 collaborates with toll-like
receptor 2 in inflammatory responses against microbial pathogens
[20].
Serpina3g. Serpin3g is a cytoplasmic inhibitor of papain-like,
and is required for the protection of cells from caspase-independent
PCD triggered by tumor necrosis factor-alpha. In the absence of
Table 2. TaqManH Custom Array microfluidic card system was used to assess expression status at the mRNA level of 18 selected
genes (see Table 1) in reference to 5 reference genes (Gapdh, Est1, Rlp3, Mdh-1, Rpl37).
# REFSEQ ID GENE Gapdh contr./inf. Est1 contr./inf. Rpl23 contr./inf. Mdh-1 contr./inf. Rpl-37 contr./inf.
OVEREXPESSED/UPREGULATED
Immune response/defense [functional group]: Macrophages (MØ)
02 NM_011579 Tgtp 9.7 8.2 8.8 11.1 10.7
08 NM_010766 Marco 6.3 5.1 5.6 7.0 6.8
12 NM_020008 Clec7a 4.0 3.3 3.7 4.5 4.4
13 NM_013563 Il2rg 3.7 3.2 3.5 4.2 4.2
14 NM_010705 Lgals3 3.5 3.0 3.3 4.1 3.9
10 NM_009283 Stat1 2.9 2.5 2.7 3.3 3.4
Immune response/defense [functional group]: APC
17 NM_011579 H2-Eb1 (Ab1) 6.8 5.9 6.3 7.8 7.5
19 NM_010386 H2-Dma (H2aa) 5.9 5.0 5.4 6.7 6.4
20 NM_010387 H2-DMb1 (H2-
Eb1)
6.3 5.3 5.7 7.1 6.7
21 NM_001042605 Cd74 5.7 4.9 5.3 6.6 6.2
Immune response/defense [functional group]: APC
22 NM_008599 Cxcl9 6.5 5.5 5.6 7.3 7.0
23 NM_207105 Ccl5 6.0 5.1 5.9 7.0 6.8
24 NM_021274 Cxcl10 6.2 5.0 5.0 6.9 6.2
25 NM_021718 Ms4a4b 4.8 3.8 4.2 5.3 5.2
29 NM_008013 Fgl2 3.4 2.8 3.1 3.8 3.7
28 NM_010745 Ly86 3.3 2.6 2.8 3.6 3.4
30 NM_011693 Vcam1 3.0 2.6 2.9 3.5 3.5
Intermediary metabolism [functional group]: hepatocytes
35 NM_008509 Lpl 3.5 2.9 3.5 4.0 4.0
CONTROLS 18s 1.5 1.1 1.2 1.6 1.5
standards Gapdh 1.0 1.6 1.7 1.7 1.7
Est1 2.0 1.0 1.8 2.2 2.3
Rlp23 1.7 1.4 1.0 1.9 2.0
Mdh-1 1.5 1.2 1.3 1.0 1.7
Rpl37 1.5 1.3 1.4 1.7 1.0
Values correspond to mean of 5 infected animals (inf.) or 3 non-infected control animals (contr.).
doi:10.1371/journal.pone.0009779.t002
Hepatic Gene Expression in AE
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caspase activity, Spi2A suppressed PCD by inhibiting cathepsin B
after it was released into the cytoplasm. Spi2A also directly protects
against ROS-mediated PCD, which is consistent with a role in
suppressing caspase-independent pathways of PCD. Inhibition of
lysosomal executioner proteases by Spi2A is a physiological
mechanism by which cells are protected from caspase-
independent programmed cell death [21].
Immune response/defense [APC]; up-regulated
H2-Ab1, H2-Eb1, H2-aa, H2-Dma, H2-DMb1. Activation
of naive CD4 T cells by dendritic cells requires the sequential
interaction of many TCR molecules with peptide-class II
complexes of the appropriate specificity. Such interaction results
in morphological transformation of class II MHC-containing
endosomal compartments. It is generally accepted that MHC II
alleles may influence T-cell functions by restricting TCR access to
specific residues of the I-A-bound peptide. Thus, this is of
significance to diseases that display genetic linkage to specific
MHC II alleles, which, however, has not yet been demonstrated
for neither murine nor human alveolar echinococcosis.
CD74. Dendritic cells (DCs) sample peripheral tissues of the
body in search of antigens to present to T cells. This requires two
processes, antigen processing and cell motility, originally thought
to occur independently. The major histocompatibility complex
II-associated invariant chain (Ii or CD74), a known regulator of
antigen processing, negatively regulates DC motility in vivo [22].
Immune response/defense [Lymphocytes, chemokines
and regulation]; up-regulated
CXCL9, CXCL10. CXCL9 is a proinflammatory monokine,
induced by interferon-gamma, which supports Th1-cell mediated
tissue inflammation [23]. CXCL10 regulates liver innate immune
response [24], its role in alveolar echinococcosis is still unknown.
It is generally accepted to potentiate the gene expression of
iNOS and CXC chemokine ligand 10 (CXCL10), a major
chemoattractant of T helper cell type 1 [25]. This protein is also
expressed as a marker of hepatic inflammation and injury,
suggesting a role in liver repair and regeneration [26].
CCL5 (RANTES). CCL5 expression correlates with resistance,
and blockade of CCL5 rendered mice more susceptible to infection.
CCL5 is part of the cascade of events leading to efficient parasite
control such as in L. major infection. CCL5 up-regulates IL-12,
IFN-gamma, and migration of Th1 cells, particularly memory T
cells [27].
Ms4a4b. MS4a4B was reported to be expressed in Th1-cells
but not Th2-cells. Overexpression of MS4a4B in primary CD4+
T-cell blasts enhanced T-cell receptor (TCR)-induced Th1
cytokine production. This suggested that MS4a4B expression is
tightly regulated during T-cell development and that MS4a4B
expression promotes Th1 function and/or differentiation [28].
Cdkn1a (P21). P21 plays an essential role in determining
the type of cell death, positively for apoptosis and negatively
for autophagy [29]. Genetic inactivation of p21 in JNK12/2
mice restored hepatocyte proliferation in models of both liver
carcinogenesis and liver regeneration, and overexpression of
c-Myc increased proliferation of JNK12/2 liver cells.
Pharmacologic inhibition of JNK reduced the growth of both
xenografted human HCC cells and chemically induced mouse
liver cancers. These findings provide a mechanistic link between
JNK activity and liver cell proliferation via p21 and c-Myc and
suggest JNK targeting can be considered as a new therapeutic
approach for HCC treatment. [30].
Figure 1. Schematic hepatic cell type interaction profile linked to differentially expressed genes. Interaction of cell types in mouse livers
infected with E. multilocularis metacestodes as suggested by the pattern of differentially expressed genes (numbers in brackets) shown in Table 1.
Interactions indicated by dashed arrows are hypothetical.
doi:10.1371/journal.pone.0009779.g001
Hepatic Gene Expression in AE
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Ifi205. Ifi205 belongs to the class of interferon inducible p200
proteins that regulate cell proliferation. Ifi205 has been shown to
upregulate the cell cycle inhibitor P21 by interacting with p53
[31].
Ly86 (MD1). Ly86 contributed to LPS-induced B-cell pro-
liferation, antibody production, and B7.2/CD86 up-regulation [32].
FGL2. FGL2 inhibits dendritic cell maturation and induces
apoptosis of B cells through binding to the low-affinity FcgammaRIIB
receptor, and thus contributes to Treg cell activity [33]. There is
evidence FGL2 exerts immunosuppressive effects on T cell
proliferation and DC maturation [34].
VCAM-1. Vascular cell adhesion molecule-1 (VCAM-1) medi-
ates cell adhesion and transendothelial migration of leukocytes.
These molecules do not play a direct role in the recruitment of
leukocytes to the infected liver, but instead contribute to IL-12p40-
production by splenic CD8(+) dendritic cells (DC). This can be
associated with reduced anti-parasitic CD4(+) T cell activation in
the spleen and lowered hepatic IFN-gamma, TNF and nitric oxide
production. Such effects can be associated with enhanced parasite
growth in the liver [35].
Rgs2 (29). Rgs (regulator of G protein signaling) proteins
have been characterized as inhibitors of signal transduction
cascades initiated by G-protein coupled receptors. Rgs2 is widely
expressed in mouse and human tissues. Knock-down studies have
shown that Rgs2 is important for T-cell-proliferation and
interleukin production [36].
Immune response/defense [eosinophils]; up-regulated
Ear2 (EDN). Based on its ability to serve as a chemo-
attractant and activator of DCs, as well as the capacity to enhance
antigen-specific immune responses, Ear2 (eosinophil-associated
ribonuclease 4) is considered to have the properties of an
endogenous alarmin that alerts the adaptive immune system for
preferential enhancement of antigen-specific Th2 immune
responses [37]. Furthermore, anti-microbial actiovities have been
documented by Nakajima et al. [38]. Mouse EAR2, is also
chemotactic for human as well as mouse DCs [39].
Intermediary metabolism [hepatocytes]; up-regulated
Lpl. Lipoprotein lipase (Lpl) binds to lipoproteins and specific
cell surface proteins in a non-catalytic way. Lpl is expressed in a
tissue-specific pattern during development with an increase in
adipose tissue, but a decrease in liver. Interestingly, Lpl is also
expressed in macrophages where interleukins and interferons
downregulate and free fatty acids upregulate expression [40].
Conclusively, an increase would suggest the differentiation of
adipocytes in the infected liver.
Hk3. Hexokinase III has a very high affinity for glucose, is
inhibited by glucose at higher concentrations. Given the specific
catalytic patterns, hexokinase III is most likely involved in anabolic
processes, e.g. lipid biosynthesis, by providing NADPH by the
pentose phosphate pathway [41].
Immune response/defense [Lymphocytes, chemokines
and regulation]; down-regulated
Pim3. Pim3 is expressed at low levels in the liver, but
upregulated in malignant liver tissue [42]. Pim 3 phosphorylates
and thus inactivates the pro-apoptotic protein Bad. The active Bad
protein binds to anti-apoptotic proteins of the Bcl2 family thus
allowing induction. By phosphorylation of Bad, binding sites for
14-3-3-protein are created. The resulting Bad-14-3-3-complex is
no longer able to interfere with Bcl2 proteins thus preventing cell
death [43].
Intermediary metabolism [hepatocytes]; down-regulated
Crotonase homologous. Crotonase (Enoyl-coenzyme-A-
hydratase) catalyses the hydratation of trans-2-enoyl-CoA
thioesters resulting from the first step of beta-oxidation of fatty
acids [44].
Discussion
Functional analysis, immunostimulatory pathway
The involvement of cellular immunity in controlling the
infection is strongly suggested by the intense granulomatous
infiltration observed in the periparasitic area of lesions in
experimentally infected mice [45,46]. Immunodeficient athymic
nude [47] and SCID mice [48] as well as HIV-co-infected patients
[49,50] exhibited high susceptibility to infection and disease, thus
suggesting that the host cell mediated immune response plays an
important role in suppressing the larval growth. E. multilocularis
appears to induce skewed Th2-responses [46]. Based on in vitro
and in vivo studies, Th2-dominated immunity was associated with
increased susceptibility to disease, while Th1 cell activation
through IL-12 [46], IFNc [51,52], TNFa [53] and IFNa [54]
was suggested to induce protective immunity in AE [55,56]. Innate
mechanisms appeared also to resistance upon attack by cytotoxic
compounds such as activated complement proteins and NO,
associated to increased macrophage activities [57,58]. With regard
to the hepatic gene expression profiles of our study related to
immunostimulatory pathways (thus potentially also to efficient host
control mechanisms), most of the highest expressed molecules
(BC023105, Tgtp, Gvin1, GBPs, Clec7a) appear to localize within
cytokine pathways involved in direct or indirect MØ activities.
Respective parasite cell damage may be one option, but also
subsequent antigen processing (MARCO: carbohydrates? Ly86:
LPS-like antigens?) and orchestration of the subsequent T cell
orientation (STAT1, Mcm5, Il2rg, Pleckstrin, Lgals3). Beside MØ,
dendritic cells may intrahepatically contribute to the immunolog-
ical response and defense, as indicated by hyperexpressed partner
cell (e.g. CD4 T cells) molecules such as H2-Ab1, H2-Eb1, H2-aa,
H2-Dma, H2-DMb1, CD74 and CCL5, all associated to CD4 T
cell activation and action, especially Th1 (CCL5, Ms4a4b, Rgs2).
That all these events are accompanied by periparasitic inflamma-
tory processes are supported by overexpressed CXCL9, CXCL10.
Finally, another hyperexpressed molecule (Serpina3g) may
synergistically contribute to parasitocidal host effector mechanisms
by controlling immunopathological events related to apoptotic
tissue damage, putatively triggered by Cdkn1a, and downregulat-
ed Pim3 may contribute to such a phenomenon as well.
To carry out a more profound interpretation of the present
findings, we have to take into account that the time point of
investigation (infection status) corresponds to a rather early stage,
not yet switched into the late/chronic stage of AE. Globally, the
above listed phenomena correspond mostly to a still Th1-oriented
immune response, which may putatively be the correct way to
control infection. We know, however, that the parasite survives in
the host. By inducing functional changes in DCs and MØs, the
metacestode can achieve important shifts in T-cell subsets. The
initial acute inflammatory Th1 response is subverted gradually to a
Th2 response during the chronic phase of AE [59]. Cytokines,
such as IL-4, IL-5, IL-9 and IL-13, secreted largely by immune-
cell types in response to parasite antigens, not only down-modulate
the Th1 response but can also promote parasite expulsion and
tissue renewal and repair [60]. The metacestode most likely
achieves the late infection stage Th2 expansion through the
induction of regulatory cytokines, such as IL-10 and TGF-b [59].
To provide a platform of understanding the late stage event, we
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will have to prompt a more detailed investigation by using late
stage infection mice. The question will arise as to whether it will be
possible to obtain appropriate hepatic tissue free of metacestode
material (a prerequisite in the present study), as at the advanced/
late stage, usually the whole liver is metastatically interspersed with
parasite cells/vesicles. One of the key questions remaining is how
during the infection course the initial Th1-orientation switches to a
rather Th2-oriented pathway. Our interest will thus focus on
unraveling the metacestode tools (metabolites) that could trigger
such a re-orientation.
Functional analysis, immunosuppressive pathway
An interesting feature observed in chronic AE is a marked
depression of the cell-mediated immune response [61,62,63]. These
general characteristics of E. multilocularis, including the seemingly
tumor like growth, its ability to modulate host immune responses,
and the fact that in vitro culture is an established technique, renders
this parasite a very attractive model to study the host-parasite
interplay in view to reveal potentially novel modes of therapy [56].
Increased concentrations of the pro-inflammatory cytokines TNF-a,
IL-1b, iNOS and the anti-inflammatory IL-I0 are characteristic for
secondary AE in mice [58].
With regard to the hepatic gene expression profiles of our study
related to immunosuppressive pathways (thus potentially also to the
support of parasite survival capacities), overexpressed molecules
such as FGL2 can already interfere at early innate stage by
inhibiting dendritic cell maturation, or by reducing T cell activation
(VCAM-1). Such effects can be associated with enhanced parasite
growth in the liver [64]. Interestingly, like in many other helminthic
infections, the host immune response seems to make use of a rather
Th2-dependent eosinophilic component to trigger its fight against
the infectious agent (Ear2, EDN). The mobilization of eosinophils is
known to be a crucial immunological event that plays an important
role in the host defense against helminths. Despite appropriate host
signals, there is a marked lack of eosinophilic infiltrates in
experimental murine AE [59]. One possible explanation was
recently provided by the demonstration that E. multilocularis
metabolites exhibit proteolytic activity on eotaxin in vitro [58].
Inhibition of eotaxin activity may suppress the mobilization of
eosinophils in E. multilocularis-infected mice. Absent eosinophils thus
may be a part of a series of events that maintain a low level of
inflammation in E. multilocularis-infected hosts.
Hepato-pathogenesis
The pathogenesis of liver damage in AE arises from the
interplay of the parasitic metacestode and the host inflammatory
response. It is generally accepted that the release of parasitic
products/metabolites (such as cysteine proteases [59]) into the
periparasitic hepatic tissue triggers the inflammatory response in
the liver parenchyma by inducing the production and release of
inflammatory cytokines, chemokines and lipid inflammatory
mediators [59]. At an early stage of infection, little liver damage
is observed [65]. That may be the reason why our study yielded
few deregulated genes related to hepatocyte functions. The
upregulation of a lipoprotein lipase and a hexokinase most likely
involved in anabolism and the downregulation of crotonase are
indications for a metabolic reprogramming of hepatocytes (Fig. 1)
in the direction of fat accumulation (differentiation of adipocytes).
Recently, an apolipoprotein binding protein from E. multilocularis
hydatid fluid has been characterized [66]. These findings indicate
the parasite may act as a sink for host lipids and stimulates lipid
accumulation in vicinal host tissue. It is, however, unclear whether
E. multilocularis is able to use lipids as a source for carbon and
energy. Although it is clear that glycolysis and tricarboxylic acid
cycle are functional (yielding succinate under anaerobic condi-
tions), results concerning lipid catabolism via beta-oxidation are
lacking [67]. Host lipids may also be attracted and exposed as a
part of a strategy to circumvent the host immune system. In any
case, these proteins could be interesting targets to address in future
studies, presently these molecules remain still at a speculative level
and are difficult to discuss without further pathological character-
istics related to these molecules. At a late stage of infection, fibrosis
becomes a hallmark of AE, leading to a complete disappearance of
the liver parenchyma and even to the death of the metacestode,
with vesicles embedded in an acellular tissue composed nearly
entirely of cross-linked collagens [68]. The diffusion of the fibrotic
process even far from the parasitic lesions strongly suggests a major
role for cytokines in collagen synthesis. But these features could not
be addressed and thus also not discussed in the present study. As
mentioned above, we will design new studies respecting temporal
aspects to unravel late stage characteristics of murine AE.
Conclusion
The conventional course of AE as a disease in humans
resembles strongly that of the naturally infected mouse, in that
untreated AE will, in many but not most cases, finally lead to
fatality.
In order to better understand periparasitic events characterizing
the host response to infection, we assessed the gene expression
profile in the periparasitic liver tissue during early chronic AE.
High throughput analysis of gene expression yielded a set of mostly
immunologically related upregulated genes, while downregulation
almost exclusively lacked. The data presented herein may provide
a road map for further investigations into the pathophysiology of
AE and may help to identify potential targets for adjuvant therapy
of this disease. Future interest will also focus on unraveling similar
events but at late stage infection.
Methods
Model of alveolar echinococcosis
An established mouse model of primary alveolar echinococcosis
was used as previously described [3,69]. The animal studies were
approved by the Animal Care and Experimentation Committee of
the Canton of Bern, Switzerland, and followed National Institutes
of Health guidelines for the performance of animal experiments.
Briefly, 8-weeks-old female C57BL6/J mice were purchased from
Charles River GmbH (Germany), and infected (n= 10) at the age
of 10 weeks by peroral inoculation with 100 ml sterile water
containing 26103 eggs of E. multilocularis, using appropriate
biosafety level 3 laboratory conditions (Swiss biosafety approval
number A990006/3A). The infecting organisms (parasite eggs)
were initially isolated from a naturally infected fox. Egg viability
and infectiosity were pre-evaluated upon explorative titrated
infection experiments carried out in mice preliminarily to the
present studies [4]. Mock-infected control animals (n = 5) were
perorally inoculated with 100 ml of sterile water. 31 days after
infection, the animals were weighed and the infection intensity of
AE was scored by counting the number of parasitic lesions
macroscopically visible on and within the liver tissue [4]. Animals
were sacrificed with an overdose of pentobarbital (100 mg/kg,
intraperitoneally) for the mock-infected control group (n= 5) and
for the group representing the chronic stage of primary AE
(n= 10).
Tissue processing
Animals were perfused via the left cardiac ventricle with 30 ml
of ice-cold, RNase-free phosphate buffered saline (PBS) followed
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by 30 ml of 50% RNAlater@ (Ambion Europe Ltd., Huntingdon,
UK) in ice-cold, RNase-free PBS. Immediately afterwards, the
liver was removed. Approximately 5 mm3–sized periparasitic liver
tissue blocks (adjacent by 1 mm to the macroscopically visible
parasitc lesion) were dissected and stored separately in 150 ml of
RNAlaterH at 4uC until isolation of RNA.
RNA processing and microarray hybridization
Liver tissue samples of each animal were processed and
analyzed separately. Total RNA was extracted from liver tissue
using RNeasyH Lipid Tissue kit (QIAGEN, Basel, Switzerland)
and purified with RNeasy columns (QIAGEN, Basel, Switzerland).
Quantification and assessment of RNA integrity were performed
on the Agilent 2100 bioanalyzer platform (RNA 6000 Nano,
Agilent technologies, Waldbronn, GER) and validated on the
NanoDropH (NanoDrop, Wilmington, USA) quantification device.
Based on RNA quality control results and histopathological
evaluation of hippocampal damage (apoptosis score) RNA extracts
from 3 infected and 3 control animals were selected for each time
point for array hybridization. Double-stranded cDNAs were
synthesized from 5 mg of total RNA using an oligo dT-T7
promoter primer (Roche Molecular Biochemicals, Mannheim,
Germany). The cDNAs obtained were used as templates for in
vitro transcription using the Megascript kit purchased from
Ambion (Austin, TX) and biotinylated nucleotides (Bio-11-CTP
and Bio-16-UTP) provided by Roche Molecular Biochemicals
(Basel, Switzerland). Fragmented in vitro transcripts (cRNAs) were
hybridized overnight on to commercially available rat microarrays
(GeneChipH Rat Genome 230 2.0 Array, Affymetrix, Santa Clara,
CA) containing 31’000 probe sets representing approximately
28’000 well-substantiated rat genes. The hybridized samples were
stained with streptavidin-R phycoerythrin (SAPE, Molecular
Probes Inc., Eugene, OR) and the signal was amplified using a
biotinylated goat anti-streptavidin antibody (Vector Laboratories,
Burlingame, CA). Washing, staining and amplification were
carried out in an Affymetrix GeneChipH Fluidics Station 450.
Microarrays were scanned in an Affymetrix GeneChipH scanner
3000. Signal intensities were calculated based on image files with
the Affymetrix GeneChipH Operating software (GCOS) v1.1.1.
Raw data analysis
Chip data analysis was performed on the R platform for
statistical programming using packages of the Bioconductor
project [70]. Due to the asymmetric distribution of microarray
data all datasets were log2 transformed. Background correction,
normalization and data summary were performed with non linear
methods using the rma function of the affy package [71]. Chip
quality assessment was exploratively performed based on boxplots
of the raw log scale intensities and MA-plots visualizing signal
intensity dependent effects on the log-ratios. Additionally the
quality of the hybridized cRNA was assessed by RNA digestion
plots where the mean intensities of all probes on an array are
plotted according to their 59 to 39probeset position (affy package).
To reduce the number of hypothesis to be tested in the
subsequent significant tests, genefiltering was perfomed. All genes
that were expressed under the estimated background intensity of
60 fluorescent units (FU) on at least 4 of the 8 chips and genes
showing an interquantile range (IRQ) of less than 0.5 were
excluded from significance testing.
Significance testing was performed using the limma package
[72]. Type 1 error was corrected by the Benjamini-Hochberg false
discovery rate algorithm [73].
All raw data is MIAME compliant and have been deposited in
‘‘ArrayExpress’’ (EMBL/EBI) (accession no. E-MEXP-2615).
Custom-designed TaqManH Gene Expression Assays
In order to obtain an ex vivo confirmation of the Affymetrix gene
expression findings, we selected 18 (upregulated) out of the 36
genes initially differentially expressed, to subject them to a custom-
designed real-time PCR Applied Biosystems 7900HT Micro
Fluidic Card system. For this, TaqMan Low Density Arrays using
384-well micro fluidic cards were pre-loaded with a selection
(Table 3) of differentially expressed genes (selection was primarily
based upon the availability of standardized primer pairs to
quantitatively investigate respective gene expression).
Relative quantification was based on the reference of the following
5 constitutively expressed reference genes (Table 4). These genes
Table 3. Selected list of genes and respective primer sets to
assess expression status at the mRNA level using a TaqManH
Custom Array microfluidic card system.
# gene description
Applied Biosystems
primer sets
01 T-cell specific GTPase Tgtp-Mm00786926_s1
03 histocompatibility 2, class II antigen A, beta 1 H2-Ab1-Mm00439216_m1
04 histocompatibility 2, class II antigen E beta H2-Eb1-Mm00439221_m1
07 histocompatibility 2, class II antigen A, alpha H2-Aa-Mm00439211_m1
08 chemokine (C-X-C motif) ligand 9 Cxcl9-Mm00434946_m1
09 chemokine (C-C motif) ligand 5 Ccl5-Mm01302427_m1
10 chemokine (C-X-C motif) ligand 10 Cxcl10-Mm00445235_m1
13 macrophage receptor with collagenous
structure
Marco-Mm00440265_m1
16 CD74 antigen (invariant polypeptide of
MHC class II)
Cd74-Mm00658576_m1
19 lymphocyte antigen 86 Ly86-Mm00440240_m1
20 vascular cell adhesion molecule 1 Vcam1-Mm00449197_m1
21 membrane-spanning 4-domains,
subfamily A, member 4B
Ms4a4b-Mm00649916_m1
24 fibrinogen-like protein 2 Fgl2-Mm00433327_m1
25 signal transducer and activator of
transcription 1
Stat1-Mm00439518_m1
30 lipoprotein lipase Lpl-Mm00434764_m1
31 lectin, galactose binding, soluble 3 Lgals3-Mm00802901_m1
36 C-type lectin domain family 7, member a Clec7a-Mm00490960_m1
38 RIKEN cDNA 1810022C23 gene 18S-Hs99999901_s1
doi:10.1371/journal.pone.0009779.t003
Table 4. The custom-designed TaqManH Gene Expression
Assays were quantified upon use of 5 constitutively expressed
reference genes and corresponding primer sets, respectively.
gene description gene
Applied Biosystems
primer sets
Glyceraldehyde-3-Phosphate
Dehydrogenase
GAPDH Gapdh-Mm99999915_g1
Mitochondrial resident protein ES1 ES-1 Es1-Mm00468347_m1
Ribosomal protein 23 RPL-23 Rpl23-Mm00787512_s1
Malate dehydrogenase 1 MDH1 Mdh1-Mm00485106_m1
Ribosomal protein 37 RPL-37 Rpl37-Mm00782745_s1
doi:10.1371/journal.pone.0009779.t004
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were selected from the microarray data based on i) their minimal
variability between the control and infection group ii) their absolute
expression level covering the whole array signal range.
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